Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Antibiotic use in the treatment of soft tissue abscesses: a survey of current practice.

Rajendran PM, Young DM, Maurer T, Chambers HF, Jacobson MA, Harris HW.

Surg Infect (Larchmt). 2007 Apr;8(2):237-8. No abstract available.

PMID:
17437370
2.

Methicillin-resistant S. aureus infections among patients in the emergency department.

Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA; EMERGEncy ID Net Study Group.

N Engl J Med. 2006 Aug 17;355(7):666-74.

3.

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F.

Lancet. 2006 Mar 4;367(9512):731-9. Review.

PMID:
16517273
4.

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.

Breedt J, Teras J, Gardovskis J, Maritz FJ, Vaasna T, Ross DP, Gioud-Paquet M, Dartois N, Ellis-Grosse EJ, Loh E; Tigecycline 305 cSSSI Study Group.

Antimicrob Agents Chemother. 2005 Nov;49(11):4658-66.

5.

Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.

Jauregui LE, Babazadeh S, Seltzer E, Goldberg L, Krievins D, Frederick M, Krause D, Satilovs I, Endzinas Z, Breaux J, O'Riordan W.

Clin Infect Dis. 2005 Nov 15;41(10):1407-15. Epub 2005 Oct 6.

PMID:
16231250
6.

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C; Linezolid CSSTI Study Group.

Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6.

7.

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.

Stryjewski ME, O'Riordan WD, Lau WK, Pien FD, Dunbar LM, Vallee M, Fowler VG Jr, Chu VH, Spencer E, Barriere SL, Kitt MM, Cabell CH, Corey GR; FAST Investigator Group.

Clin Infect Dis. 2005 Jun 1;40(11):1601-7. Epub 2005 Apr 28.

PMID:
15889357
8.

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B.

N Engl J Med. 2005 Apr 7;352(14):1445-53.

9.

Methicillin-resistant Staphylococcus aureus disease in three communities.

Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.

N Engl J Med. 2005 Apr 7;352(14):1436-44. Erratum in: N Engl J Med. 2005 Jun 2;352(22):2362.

10.

High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.

Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F.

Ann Emerg Med. 2005 Mar;45(3):311-20.

PMID:
15726056
11.

Resistance to antimicrobial agents: an update.

Rybak MJ.

Pharmacotherapy. 2004 Dec;24(12 Pt 2):203S-15S. Review.

PMID:
15585450
12.

Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA.

Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F.

J Infect Dis. 2004 Nov 15;190(10):1730-8. Epub 2004 Oct 18.

PMID:
15499526
13.

An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients.

Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R, Schecter WP.

Arch Surg. 2004 Sep;139(9):947-51; discussion 951-3.

PMID:
15381611
14.

Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.

Diep BA, Sensabaugh GF, Somboonna N, Carleton HA, Perdreau-Remington F.

J Clin Microbiol. 2004 May;42(5):2080-4. Erratum in: J Clin Microbiol. 2010 Sep;48(9):3461. Somboona, Naraporn S [corrected to Somboonna, Naraporn].

15.

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.

Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, Hardy RD.

Pediatr Infect Dis J. 2004 Feb;23(2):123-7.

PMID:
14872177
16.

Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.

Lieberman JM.

Pediatr Infect Dis J. 2003 Dec;22(12):1143-51. Review.

PMID:
14688589
17.

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R.

JAMA. 2003 Dec 10;290(22):2976-84.

PMID:
14665659
18.

Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Pan ES, Diep BA, Carleton HA, Charlebois ED, Sensabaugh GF, Haller BL, Perdreau-Remington F.

Clin Infect Dis. 2003 Nov 15;37(10):1384-8. Epub 2003 Oct 17.

PMID:
14583874
20.

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

Salgado CD, Farr BM, Calfee DP.

Clin Infect Dis. 2003 Jan 15;36(2):131-9. Epub 2003 Jan 3.

PMID:
12522744

Supplemental Content

Support Center